Political Quotes

Doug Bereuter: Mr. Chairman, I very much appreciate the bipartisan opposition to the Sanders amendment as voiced, for example, by the…

On the recordMay 1, 2002
Mr. Chairman, I very much appreciate the bipartisan opposition to the Sanders amendment as voiced, for example, by the senior Democrat on the Committee on Financial Services. We can all agree on a few things. We can all agree that we hate to see American jobs lost, whether it is because of decline in the industry or because of the fact that those jobs are moved abroad. We do not want to see layoffs. The fact of the matter is, however, that sometimes one sector of a company's production simply becomes obsolete, or because of the fact that it is a labor-intensive or very low-skilled job that for economic reasons, the corporation feels it must move abroad. Mr. Chairman and colleagues, do not penalize those parts of the company that are exporting products abroad. Vote ``no'' on the Sanders amendment.
Said by
Doug Bereuter

Editor's note · Context

Addressing the bipartisan opposition to the Sanders amendment regarding job loss and corporate production.

Share

More from Doug Bereuter

Jul 15, 2003

the amendment points to an important subject, the need for prompt implementation of the Act, and we certainly think that the Committee on International Relations and other relevant committees ought to receive periodic reports and hold…

govinfo.gov
Jul 25, 2003

this Member offers his strong support for H.R. 2861, the Veterans Affairs (VA)/Housing and Urban Development (HUD) Appropriations Act for FY2004. This measure provides $60.7 billion for veterans programs including $27.2 billion for…

govinfo.gov
Apr 20, 2004

Last summer this House overwhelmingly adopted a resolution calling on the citizens of Cyprus to accept a U.N.-sponsored plan designed to end 29 years of separation and to unite the island. During the floor debate, this Member expressed the…

govinfo.gov
Jul 10, 2003

this amendment requires the Agency for Healthcare Research and Quality to spend $12 million for the conduct of research on the comparative effectiveness, cost effectiveness, and safety of drugs, biological products and devices under their…

govinfo.gov